Consolidative radiation therapy may provide a significant benefit to patients with specific subtypes of diffuse large B-cell lymphoma. READ MORE

News

Opting to forgo radiotherapy can be considered in children with Hodgkin lymphoma who achieve metabolic remission on interim PET after ABVD chemotherapy.

READ MORE

Obese children and adolescents may suffer higher rates of treatment-related mortality after chemotherapy for acute myeloid leukemia.

READ MORE

Novel oral targeted therapies for the treatment of chronic lymphocytic leukemia could raise treatment costs by 600%.

READ MORE

Research in Review

Elevated expression levels of ETS2 were a strong predictor of prognosis in AML and should be used to guide treatment decisions.

READ MORE

Immunotherapy after complete remission in acute myeloid leukemia is associated with decreasing levels of regulatory T-cells, which leads to favorable clinical outcomes.

READ MORE

A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma.

READ MORE

A recent report demonstrates the promise of programmed death inhibition in improving outcomes for patients with a rare, difficult-to-treat type of lymphoma.

READ MORE